-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editorial Foreword: Looking forward to another exciting year of Clinical Ophthalmology ||FREE PAPER||
(2153) Views (380) Full article downloads
Author: Scott G Fraser
Published Date March 2008
Volume 2008:2(1) Pages 0 - 0
DOI: http://dx.doi.org/10.2147/OPTH.S
Scott G Fraser
Sunderland Eye Infirmary; University of Sunderland; University Newcastle-Upon-Tyne. Queen Alexandra Road, Sunderland, UK
Welcome to the first edition of Clinical Ophthalmology of 2008. This is our second year of publication after an extremely busy first year. We continue to get a huge number of submissions and this has accelerated now that the journal is almost completely open access. The reasons for this acceleration may be wider access of published articles from the journal or may simply be a result of the number of excellent articles that continue to be rejected by the more established journals. The latter often cite lack of print space as a reason for this rejection – something that we at Clinical Ophthalmology will never do. If our peer reviewers feel an article is good enough, then it will be published.
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia
- Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%




